Phoebe Introduces AI-Powered HYDROS Robotic System for Treating Enlarged Prostate

Albany, GA | November 18, 2025 – Phoebe Putney Memorial Hospital (PPMH) is now offering a new treatment for men with enlarged prostates. Aquablation® therapy with the new HYDROS™ Robotic System is the next-generation platform to treat men suffering from benign prostatic hyperplasia (BPH), commonly known as an enlarged prostate.

Aquablation therapy, now delivered by an AI-powered robotic system, is clinically proven to provide significant, durable BPH symptom relief while preserving sexual function and continence across prostates of all shapes and sizes.

BPH is an unfortunate reality of aging for millions of men and impacts urinary function, making it difficult to urinate and fully empty the bladder. Common indicators that a man may be experiencing BPH include the urgent need to urinate, increased frequency, and waking during the night to urinate.

Without timely treatment, BPH can lead to severe health issues such as permanent bladder or kidney damage, bladder stones and incontinence. Around 50% of men ages 51-60 have BPH, and 99% of men say BPH impacts their quality of life. The standard treatment option today is surgery, which often impacts sexual function and continence.

With Aquablation, PPMH is investing in technology that elevates the quality of urologic care available in our community. This advanced treatment option will be accessible to both Phoebe physicians and local independent urologists.

“This investment reflects our commitment to bringing leading-edge, highly effective technologies to southwest Georgia to benefit as many people as possible. The HYDROS Robotic System allows us to offer men a level of precision, safety and outcomes that simply haven’t existed in traditional BPH treatment options,” said Deb Angerami, PPMH President.

Aquablation therapy was designed to offer a minimally invasive and effective solution for BPH. It is unique in its use of real-time, ultrasound-guided, robotic-assisted waterjet technology, allowing surgeons to create a personalized treatment plan that precisely targets which prostate tissue to remove and which to preserve. With this tailored approach, the system accurately removes problematic tissue while safeguarding critical anatomy.  The HYDROS Robotic System advances the therapy and is designed to improve efficiency, enhance surgeon and staff experience, and deliver a more accurate and consistent treatment plan for better clinical outcomes.

“BPH is a widespread condition that severely compromises quality of life for countless men over age 50. With Aquablation therapy, men can reclaim their lifestyles and find relief from symptoms while preserving sexual function and continence—outcomes that have proven elusive with many traditional treatment modalities,” said Jason Smith, MD, PPMH Chief Medical Officer.

The clinically proven procedure provides the surgeon with a multi-dimensional, detailed view of the entire prostate. Using a heat-free waterjet, the robot executes the surgeon-defined treatment plan to remove obstructive tissue while protecting critical anatomy. This enables efficient and predictable tissue removal across a wide range of prostate sizes and shapes.

If you think you could benefit from these services, please contact Phoebe Urology at 229-312-8463 to schedule an appointment for an assessment.